Those who cover green and sustainability issues know that Pharma is pretty progressive. No, the industry's not perfect, certainly, but many of its leading companies also make it a point to be leaders in environmental stewardship.
Once upon a time, I worked as a communications consultant for a major pharmaceutical, helping to educate physicians on the company’s drugs, recent trial results, changes in prescribing information, so forth and so on. I met countless physicians paid by the company as speakers and advisors—many of them nice people...
The drug industry is usually out front in assisting disaster relief, and many manufacturers have already come forth with major donations of money and supplies to Haiti in the aftermath of this week's earthquake.
Reading an article online today from the Boston Herald on how AstraZeneca is outfitting its new Waltham, Mass. R&D center with the latest and greatest green bells and whistles . . . it's good to see, but hardly surprising.
I spent yesterday afternoon at the Forum for Medical Innovation in downtown Chicago, hosted by the Council for American Medical Innovation and moderated by former U.S. House of Representatives majority leader Dick Gephardt. The event also featured AstraZeneca CEO David Brennan as a guest speaker. [img_assist|nid=1172|title=David Brennan|desc=|link=none|align=right|width=128|height=86]
Microsoft's Life Sciences Group has certainly grown, from 5 people when it was established seven years ago to 800 people today. The SharePoint platform, which allows users to customize solutions without having to play programmer is finding increased acceptance.
This week, the Second International Symposium on Green Processing in the Pharmaceutical and Fine Chemical Industries was held at Yale University in New Haven. The event brought together some of the finest minds working in green chemistry today, from industry, academia and government.